Literature DB >> 24132825

Stroke volume response to liver graft reperfusion stress in cirrhotic patients.

Bibiana Escobar1, Pilar Taurá, Graciela Martínez-Palli, Constatino Fondevila, Jaume Balust, Joan Beltrán, Javier Fernández, Juan Carlos García-Pagán, Juan Carlos García-Valdecasas.   

Abstract

INTRODUCTION: In patients with advanced cirrhosis, stressful stimuli may reveal a silent reduced cardiac performance. During liver transplantation (LT), graft reperfusion strongly stresses the heart and may unmask latent myocardial dysfunction. AIM: The objective of this study was to assess heart response to acutely increased preload after liver graft reperfusion and correlate this response with preoperative data and outcome.
METHODS: Preoperative clinical, echocardiographic, and hemodynamic data, and patient outcome were retrospectively recorded for 235 liver recipients who had no known cardiac disease. Myocardial dysfunction was defined as less than 10 % increase of stroke volume after graft reperfusion (non-responder).
RESULTS: We found 84 (35.7 %) non-responder patients. The non-responders showed higher Model for end-stage liver disease scores (p = 0.046), left atrial diameter (LAD) (p = 0.040), hepatic vein pressure gradient (p = 0.055), and hyperdynamic state than responders. The percentages of patients with hyponatremia (p = 0.048) and alcohol etiology (p = 0.025) were also higher among non-responders. Independent predictors of inadequate cardiac response in the multivariate analysis were low preoperative systemic vascular resistance (SVRI) [odds ratio (OR) 3.09, 95 % CI 1.15-4.82; p = 0.027] and enlargement of LAD (OR 2.08, 95 % CI 1.49-2.74; p = 0.044). Non-response was associated with higher rates of early cardiovascular events [hazard ratio (HR) 2.84, 95 % CI 1.09-4.22; p = 0.039] and higher length of intensive care unit stay (p = 0.038). No differences were found in 1-year survival rates.
CONCLUSIONS: Latent cardiac dysfunction among LT recipients, considered to be abnormal stroke volume response to unclamping of portal vein, is very prevalent. SVRI and LAD were independent predictors of inadequate responses. This condition deserves special attention since it may aggravate the early postoperative course of LT.

Entities:  

Mesh:

Year:  2014        PMID: 24132825     DOI: 10.1007/s00268-013-2289-x

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  36 in total

1.  An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis.

Authors:  Angelo Luca; Berhard Angermayr; Guido Bertolini; Franz Koenig; Giovanni Vizzini; Martin Ploner; Markus Peck-Radosavljevic; Bruno Gridelli; Jaime Bosch
Journal:  Liver Transpl       Date:  2007-08       Impact factor: 5.799

Review 2.  Cirrhotic cardiomyopathy.

Authors:  Enrico M Zardi; Antonio Abbate; Domenico Maria Zardi; Aldo Dobrina; Domenico Margiotta; Benjamin W Van Tassell; Benjamin W Van Tassel; Antonella Afeltra; Arun J Sanyal
Journal:  J Am Coll Cardiol       Date:  2010-08-10       Impact factor: 24.094

3.  Cirrhotic cardiomyopathy.

Authors:  Florence Wong
Journal:  Hepatol Int       Date:  2008-11-11       Impact factor: 6.047

Review 4.  Assessment of portal hypertension in humans.

Authors:  A Escorsell; J C Garcia-Pagán; J Bosch
Journal:  Clin Liver Dis       Date:  2001-08       Impact factor: 6.126

Review 5.  Cirrhotic cardiomyopathy.

Authors:  Søren Møller; Jens H Henriksen
Journal:  J Hepatol       Date:  2010-03-31       Impact factor: 25.083

6.  Pulmonary edema in patients after liver transplantation.

Authors:  C P Snowden; T Hughes; J Rose; D R Roberts
Journal:  Liver Transpl       Date:  2000-07       Impact factor: 5.799

7.  Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt.

Authors:  Massimo Cazzaniga; Francesco Salerno; Giovanni Pagnozzi; Elena Dionigi; Stefania Visentin; Ilaria Cirello; Daniele Meregaglia; Antonio Nicolini
Journal:  Gut       Date:  2006-11-29       Impact factor: 23.059

8.  Prediction of cardiac complications after liver transplantation.

Authors:  Tamer R Fouad; Wael M Abdel-Razek; Kelly W Burak; Vincent G Bain; Samuel S Lee
Journal:  Transplantation       Date:  2009-03-15       Impact factor: 4.939

9.  Perioperative risk predictors of cardiac outcomes in patients undergoing liver transplantation surgery.

Authors:  Anas Safadi; Mohamed Homsi; Waddah Maskoun; Kathleen A Lane; Inder Singh; S G Sawada; Jo Mahenthiran
Journal:  Circulation       Date:  2009-09-14       Impact factor: 29.690

10.  Cardiovascular complications of cirrhosis.

Authors:  S Møller; J H Henriksen
Journal:  Postgrad Med J       Date:  2009-01       Impact factor: 2.401

View more
  4 in total

Review 1.  Post reperfusion syndrome during liver transplantation: From pathophysiology to therapy and preventive strategies.

Authors:  Antonio Siniscalchi; Lorenzo Gamberini; Cristiana Laici; Tommaso Bardi; Giorgio Ercolani; Laura Lorenzini; Stefano Faenza
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

2.  Venous Thrombotic Events After Liver Transplantation.

Authors:  Annabel Blasi; Virginia Hernandez; Javier Fernandez; Jordi Colmenero; Joan Beltran; Juan Carlos Garcia-Valdecasas; Joan Carles Reverter
Journal:  Clin Appl Thromb Hemost       Date:  2016-11-28       Impact factor: 2.389

Review 3.  Cirrhotic cardiomyopathy.

Authors:  Luis Ruiz-del-Árbol; Regina Serradilla
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

Review 4.  Cardiac risk stratification of the liver transplant candidate: A comprehensive review.

Authors:  Sanjana Nagraj; Spyros Peppas; Maria Gabriela Rubianes Guerrero; Damianos G Kokkinidis; Felipe I Contreras-Yametti; Sandhya Murthy; Ulrich P Jorde
Journal:  World J Transplant       Date:  2022-07-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.